Status:
COMPLETED
Community Pharmacists Vaccinate Against Cancer
Lead Sponsor:
Arizona State University
Collaborating Sponsors:
Adelante Healthcare
National Institute on Minority Health and Health Disparities (NIMHD)
Conditions:
Human Papillomavirus Vaccines
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
Latino and African American populations have a higher rate of human papillomavirus (HPV) vaccine initiation; however, they have a significantly less likelihood of completing the vaccine series. Pharma...
Detailed Description
Human papillomavirus (HPV) is the most common sexually transmitted infection, and persistent infection with oncogenic HPV strains causes cancer. Commercially available 9-valent HPV vaccines offer the ...
Eligibility Criteria
Inclusion
- Caregivers of a child between ages 9-18 who has either not received any HPV vaccine doses or has received only initial HPV dose
- Receives care at Adelante Healthcare Mesa
- Fluent in English and/or Spanish
- Willing to provide informed consent
Exclusion
- Caregivers whose child has completed additional HPV vaccine doses
- Child is over age 18 years (no caregiver consent needed)
Key Trial Info
Start Date :
April 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2021
Estimated Enrollment :
33 Patients enrolled
Trial Details
Trial ID
NCT04072159
Start Date
April 1 2019
End Date
February 1 2021
Last Update
February 28 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Adelante Healthcare Mesa
Mesa, Arizona, United States, 85201